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Molecular chaperones facilitate and regulate protein conformational change within cells. This
encompasses many fundamental cellular processes: including the correct folding of nascent chains;
protein transport and translocation; signal transduction and protein quality control. Chaperones are,
therefore, important in several forms of human disease, including neurodegeneration. Within the retina,
the highly specialized photoreceptor cell presents a fascinating paradigm to investigate the
specialization of molecular chaperone function and reveals unique chaperone requirements essential
to photoreceptor function. Mutations in several photoreceptor proteins lead to protein misfolding
mediated neurodegeneration. The best characterized of these are mutations in the molecular light
sensor, rhodopsin, which cause autosomal dominant retinitis pigmentosa. Rhodopsin biogenesis is
likely to require chaperones, while rhodopsin misfolding involves molecular chaperones in quality
control and the cellular response to protein aggregation. Furthermore, the specialization of components
of the chaperone machinery to photoreceptor speciﬁc roles has been revealed by the identiﬁcation of
mutations in molecular chaperones that cause inherited retinal dysfunction and degeneration. These
chaperones are involved in several important cellular pathways and further illuminate the essential and
diverse roles of molecular chaperones.
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1.1. Molecular chaperone function
Molecular chaperones are facilitators and regulators of protein
conformational change (Ellis and Hartl, 1999). Importantly, they
do not provide information with regard to the ﬁnal protein
structure. Chaperones bind to and stabilize conformers of other
proteins, and via cycles of regulated binding and release are able
to facilitate the correct fate of their client protein and reduce
protein aggregation (Dobson, 2004). Through this mechanism,
molecular chaperones play an essential role in many cellular
processes. They have a principal role in protein folding, where
they are involved in the de novo synthesis of polypeptides (Hartl
and Hayer-Hartl, 2002), transport across membranes (Rapoport,
2007) and the refolding of proteins denatured by environmental
stress (Nollen and Morimoto, 2002). The ability to respond to
cellular stress is reﬂected by many molecular chaperones also
being stress response proteins and bearing the name ‘heat shock
protein’ (or Hsp) followed by an approximate molecular weight
(e.g. Hsp70). Molecular chaperones also function in the oligomeric
assembly and disassembly of protein complexes, controlled
switching between active and inactive conformations of client
proteins, intracellular transport and protein quality control and
degradation (Ellis, 2006).
More than 20 different families of proteins have chaperone
activity. The major chaperone families include the Hsp90, Hsp70,
Hsp60 (chaperonins), Hsp40 (DnaJ) and small heat shock proteins
(sHsps). These different chaperone families provide different
structural solutions to the problems of protein folding (Fig. 1).
The best-studied and mechanistically understood chaperone
machines are Hsp70 and Hsp60 families. These chaperones
recognize and interact with unfolded or partially folded polypep-
tides by binding to exposed hydrophobic regions within proteins
preventing them from aggregating and maintaining them in a
folding competent state until release. This is particularly im-
portant as the nascent polypeptide emerges from the ribosome
(Kaiser et al., 2006). Efﬁcient folding of a newly synthesized
polypeptide chain is achieved by a transient interaction with the
chaperone that prevents aggregation due to unwanted interac-
tions with hydrophobic regions of other proteins or within the
extending polypeptide (Dobson, 2004).
The different families of chaperone proteins recognize various
intermediates of non-native polypeptides and interact through
different modes of binding (Fig. 1). Hsp70 proteins bind to short
regions of peptides with a certain position and pattern of
hydrophobic residues in a substrate-binding pocket resembling
a ‘clamp’ (Jiang et al., 2005). In contrast, Hsp60 (chaperonins)
facilitate folding by enclosing non-native polypeptides in the
central cavity (or ‘cage’) of a ring structure formed from identical
or closely related rotationally symmetrical subunits (Rye et al.,
1999). Another example of chaperone activity is the peptidyl–
prolyl cis–trans isomerase (PPIase) activity found in the cyclophi-
lins (e.g. NinaA) that overcomes a rate limiting step in protein
folding, the correct orientation of proline residues (Yaffe et al.,
1997; Andreotti, 2003).
Molecular chaperones are a group of functionally related but
otherwise diverse protein families. These families are conserved
among the vast majority of prokaryotic and eukaryotic organismsand members of each family occupy both cytosol and endoplasmic
reticulum (ER). The following is a brief description of the
properties of these families.1.2. Major chaperone families
1.2.1. Hsp90
Members of the Hsp90 family of chaperones are present in
most cellular compartments such as the cytosol, the ER, mitochon-
dria and the chloroplast in plants. Hsp90 functions as a homo-
dimer, and can be divided into three domains, an N-terminal
ATPase domain, a ‘middle’ domain and a C-terminal domain. The
structure of the N-terminal domain was the ﬁrst to be solved
(Prodromou et al., 1997) and revealed an atypical ATP binding
pocket, resolving the controversy over whether Hsp90 was capable
of nucleotide binding. The ATP binding pocket is the site of binding
for the macrocyclic antitumor agent geldanamycin (Prodromou
et al., 1997). Geldanamycin binding to Hsp90 can disrupt
productive complexes with protein kinase and steroid hormone
receptor clients (Mimnaugh et al., 1996). The action of geldana-
mycin and related compounds is attributed to their action as
competitive inhibitors of ATP binding which is essential for Hsp90
function (Obermann et al., 1998). Recently, the ‘closed’ structure of
an Hsp90 dimer in contact with the co-chaperone p23 was solved
and revealed that Hsp90 does not enclose its client proteins but
provides a bipartite binding surface whose formation and disrup-
tion are coupled to the chaperone ATPase cycle (Ali et al., 2006;
Fig. 1). Hsp90 fulﬁls its chaperone functions at the core of a
multiprotein complex that incorporates other chaperones and an
assortment of co-chaperones. Many Hsp90 co-chaperones contain
a tetratricopeptide repeat (TPR) domain but other than this
structural feature they are largely different. TPR containing co-
chaperones interact with the C-terminus of Hsp90 and facilitate
diverse functions (Prodromou et al., 1999). For example, the E3
ubiquitin ligase CHIP functions in targeting Hsp90 client proteins
to the proteasome (Jiang et al., 2001).1.2.2. Hsp70
The Hsp70 family has several members that are both stress-
inducible (Hsp70, Hsp70i) and constitutively expressed (Hsc70).
There are forms in most cellular compartments including
cytoplasm and nucleus (Hsc70), mitochondria (Hsp75, mortallin
or mtHsp70), and endoplasmic reticulum (Grp78 or BiP) (Mayer
and Bukau, 2005). Hsp70 proteins have an N-terminal ATPase
domain and a C-terminal substrate binding (or client binding)
domain (Fig. 1). ATP hydrolysis in the N-terminal domain is linked
to a conformational change in the client binding domain (Vogel
et al., 2006). The client protein binding domain has a base of beta
strands and a ‘lid’ that is closed upon ATP hydrolysis to form a
‘clamp’ (Jiang et al., 2005). This clamp binds short extended
hydrophobic regions within client proteins and prevents them
from aggregation (Jiang et al., 2005). Hsp70 proteins can also
bind apparently native proteins, such as the un-coating of clathrin
from clathrin cages (Ungewickell et al., 1995). The versatility
displayed by the Hsp70 family is achieved through extensive
employment of co-chaperones, including Hsp40 proteins,
and a range of nucleotide exchange factors (NEFs). TPR containing
co-chaperones also bind Hsp70, e.g. Hop (Scheuﬂer et al., 2000).
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The Hsp60 family, also known as the chaperonins, form large
ring assemblies that assist protein folding (Fig. 1). Two classes of
chaperonin have been identiﬁed: type I and type II. Type I
chaperonins are similar to bacterial GroEL and are composed of
two seven-membered rings that are usually homomeric. These are
found in mitochondria (Hsp60), chloroplasts (Rubisco binding
protein), and the eubacterial cytosol (GroEL). Type II chaperonins
are still formed of two rings but the rings are more diverse and are
usually composed of several different subunits. In archaebacteria
the type II chaperonin is known as the thermosome and the
chaperonin of the eukaryotic cytosol is known as CCT or TRiC
(Horwich et al., 2007). These chaperonins have co-chaperones (or
co-chaperonins), such as GroES for GroEL and phosducin-like
proteins for CCT. GroEL and GroES function together to form a
‘two-stroke engine’ for protein folding that is regulated by ATP
binding, hydrolysis and release in the different rings (Rye et al.,
1999). Client proteins are bound within a central cavity, GroES
binds and upon ATP hydrolysis the clients are released into the
now encapsulated cavity to fold productively before ﬁnally being
released as a native protein or rebound by the chaperone system.
1.2.4. Hsp40 (DnaJ)
The Hsp40 or DnaJ family of chaperones are deﬁned by the
presence of a highly conserved 70 amino acid J-domain, which is
found at the N-terminus of Escherichia coli DnaJ (Pellecchia et al.,
1996). The J-domain has two anti-parallel alpha helices joined by
a loop that contains the HPD motif and two other alpha helices
that stabilize the structure (Fig. 1). Outside of this J-domain,
Hsp40 proteins can be extremely diverse and have been classiﬁed
on the basis of their domain conservation with DnaJ as type I, full
domain conservation; II, conservation of N-terminal J-domain and
neighboring G/F domain; or III, J-domain alone (Cheetham and
Caplan, 1998). Consequently, the Hsp40 family has a wide range of
molecular weights from less than 20 to over 500kDa. This is
probably the most diverse and numerous of the chaperone
families with over 50 different human proteins that contain a
J-domain or J-like domain, which has imperfect conservation of an
HPD motif within the J-domain. The J-domain mediates the
interaction of Hsp40 proteins and their partner Hsp70s (Hennessy
et al., 2005).
1.2.5. Small Hsps (sHsps)
The molecular mass of these chaperones ranges from 15 to
42kDa monomers that come together to form dynamic oligomeric
structures, based around dimer subunit assembly (Haslbeck,
2002). The major lens proteins the a-crystallins are members of
this family of chaperones. The sHsps share a conserved
‘a-crystallin domain’ of approximately 90 residues in the
C-terminal part of the protein (Haslbeck, 2002). These chaperones
are not thought to be regulated by nucleotide binding and release
but their function and oligomerization are regulated by phos-
phorylation and temperature. For example, the dimer of Hsp26
speciﬁcally recognizes and binds unfolded polypeptide chains
(Haslbeck et al., 1999). Following phosphorylation, the oligomeric
structure of sHsps undergoes changes. Phosphorylation of Hsp27
leads to its dissociation and reduced chaperone activity (Rogalla
et al., 1999). In contrast Hsp25 showed chaperone activity as a
hexadecamer (Ehrnsperger et al., 1999). sHsps do not appear to
have dedicated co-chaperones but instead seem to network with
other chaperone families.
1.2.6. Calnexin and lectin chaperones
The ER uses the glycosylation of proteins in conjunction with
lectin chaperones to monitor protein folding and enhance qualitycontrol. Calnexin is a type I transmembrane protein that interacts
with monoglucosylated intermediates bearing the sugar appen-
dage Glc1Man7–9GlcNAc2. Calnexin has a soluble homologue,
calreticulin, that is resident in the ER lumen. Nascent glycopro-
teins associate with calnexin and calreticulin through cycles of
binding and release (Molinari et al., 2004). This cycle is essential
for quality control as its exposes unfolded glycoproteins to folding
factors and accessory enzymes, which direct correct protein
folding (Ellgaard and Helenius, 2003). ERp57 is one of these
factors thought to be recruited to folding glycoproteins through its
interaction with calnexin or calreticulin (Lindquist et al., 2001)
although ERp57 may also function as an unassisted chaperone
(Peaper et al., 2005).1.3. Regulation of molecular chaperone function
For many chaperones, cycles of client protein binding and
release are coupled to conformational changes in the chaperone
protein that are dependent on the hydrolysis and exchange of ATP.
This process is regulated by protein cofactors known as co-
chaperones. Co-chaperones function synergistically with the
major chaperones in protein folding and often have independent
chaperone activity, but their major role may be to provide these
folding machines with speciﬁcity in client protein binding. For
example, the Hsp70 protein machinery achieves its multiple
cellular functions because of various co-chaperone proteins, such
as the Hsp40 (DnaJ) family that stimulate Hsp70 ATP hydrolysis
through their conserved J-domain and other co-chaperones that
regulate nucleotide exchange (Fig. 2). In this model, the client
protein is presented to Hsp70 by the Hsp40 co-chaperone, or
Hsp70 is activated by an Hsp40 to bind a client nearby (Cheetham
and Caplan, 1998). The bound client can be stabilized on Hsp70
by the Hsp70 interacting protein (Hip) or its release can be
stimulated by an exchange factor, such as Bag1 or HspBP1
(Hohfeld and Jentsch, 1997; Kabani et al., 2002). The released
client protein may fold to the native state or enter another cycle of
chaperone binding and release. If the client spends too long in the
chaperone system or if it is targeted by specialized co-chaperones
it will be sorted for degradation by the proteasome (Westhoff
et al., 2005).
In addition to the J-domain there are some other common co-
chaperones motifs. For example, Hip (Hohfeld and Jentsch, 1997),
Hop (Scheuﬂer et al., 2000), CHIP (Connell et al., 2001) and the
immunophilins, including AIPL1 (Sohocki et al., 2000), use a
degenerate 34 amino acid repeat motif, the TPR to promote
chaperone/co-chaperone interactions and modify chaperone
function.
In addition, there is functional co-operation between the
individual chaperone machines. For example, the Hsp70/Hsp90
organizing protein (Hop) functions to bring together these
two chaperone machines to form a larger chaperone heterocom-
plex (Scheuﬂer et al., 2000). This chaperone heterocomplex of
Hsp70, Hsp90 and several co-chaperones functions in the
assembly of the steroid receptor and transcription factor
complexes (Morishima et al., 2000). Similarly, the Hsp70
chaperone machine may pass nascent chains onto Hsp60
to complete folding (Frydman et al., 1994) and sHsps may
sequester denatured proteins preventing them from aggregation
until another chaperone system can facilitate their folding or
degradation (Lee et al., 1997; Lee and Vierling, 2000). Through
these complementary but distinct roles in protein folding,
molecular chaperones can facilitate changes in protein conforma-
tion from initial folding through function and ultimately to
degradation. These protein folding machines can also be ﬁnely
tuned to fulﬁl speciﬁc roles within cells. The highly specialized
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Fig. 1. Different structural solutions to client protein binding in the major families of molecular chaperones. Ribbon diagrams showing representations of the structures and
client protein binding sites of the following chaperones. (A) Yeast Hsp90 dimer in complex with co-chaperone p23/Sba1 and ATP analogue (Ali et al., 2006). PDB accession
number 2CG9. (B) Amino acids 1–554 of bovine Hsc70 lacking the 10kDa C-terminal domain (Jiang et al., 2005). PDB accession number 1YUW. (C) The bacterial type I
chaperonin (Hsp60 family) GroEL consisting of two stacked homoheptameric rings (Braig et al., 1994) viewed from above one ring. PDB accession number 1GR1. (D)
Hexameric structure of an archaeal homologue of prefoldin (Siegert et al., 2000). PDB accession number 1FXK. (E) Dodecameric structure of Hsp16.3 from Mycobacterium
Tuberculosis (Kennaway et al., 2005) showing dimer subunits. PDB accession number 2BYU. (F) The J-domain of human Hsp40 family member HDJ-1 (Qian et al., 1996). PDB
accession number 1HDJ. (G) Structure of the calnexin luminal domain (Schrag et al., 2001). PDB accession number 1JHN. In all structures a-helices are shown in blue and b-
sheets in red. Scale bar represents 10 angstroms.
M. Kosmaoglou et al. / Progress in Retinal and Eye Research 27 (2008) 434–449 437photoreceptor cell, like all other cells, uses the chaperone
machinery to perform fundamental cellular functions and it also
exploits the capacity for specialization to meet its own speciﬁc
biology.2. Molecular chaperones in retinal degeneration
The neural sensory retina is a highly specialized part of the
CNS. Inherited retinal dystrophies are characterized by a great
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Fig. 2. Co-chaperone regulation of chaperone function. Schematic diagram of the
Hsp70 nucleotide based reaction cycle. In this model, the client protein is
presented to Hsp70 by the Hsp40 co-chaperone, or Hsp70 is activated by Hsp40 to
bind a client nearby. The bound client can be stabilized on Hsp70 by the Hsp70
interacting protein (Hip) or release stimulated by a nucleotide exchange factor,
such as Bag1 or HspBP1. The released client protein may fold to the native state or
enter another cycle of chaperone binding and release. If the client spends too long
in the chaperone system, or if it is targeted by specialized co-chaperones, it will be
sorted for degradation by C-terminus of Hsp70 interacting protein (CHIP) and
subsequently degraded by the proteasome (Hohfeld and Jentsch, 1997; Hennessy
et al., 2005).
M. Kosmaoglou et al. / Progress in Retinal and Eye Research 27 (2008) 434–449438degree of phenotypic and genetic heterogeneity with over 120
different disease genes implicated (RetNet, http://www.
sph.uth.tmc.edu/RetNet/). Mutations in many of these essential
retinal genes can result in protein misfolding with subsequent loss
of normal protein function. The misfolded protein can also acquire
new, toxic gains of function thought to be associated with
aggregation of the misfolded protein. Loss of protein function is
usually associated with disease gene mutations resulting in
recessive disease or haplo-insufﬁcient dominant disease, whereas
other dominant disease mechanisms will be associated with gain
of function or dominant negative effects of genetic mutations. In
this review, we will focus on how advances in the genetics and
pathogenesis of inherited retinal disease have revealed specialized
roles for molecular chaperones in the light sensitive photorecep-
tor cells. In particular, we will focus on the role of chaperones in
response to protein misfolding disease and mutations in putative
chaperones that cause retinal degeneration.2.1. Mutations in rhodopsin cause retinitis pigmentosa
Retinitis pigmentosa (RP) is a genetically heterogeneous group
of diseases that converge in their symptoms and in the manner in
which the retina is affected. Patients present with night blindness
and loss of peripheral vision, as the rod photoreceptor cells
dysfunction and die followed by cone photoreceptor cell death.
The disease then progresses towards the centre of the retina,
leading to characteristic tunnel vision and eventual blindness. RP
has multiple modes of inheritance: 15–20% of all cases are
autosomal dominant (ADRP), 20–25% are autosomal recessive
(arRP), 10–15% are X-linked (XLRP), and the remaining 40–55%
cannot be classiﬁed genetically (Wang et al., 2005; Daiger et al.,
2007). Examples of retinal disease genes that have beenassociated with protein misfolding are summarized in Table 1.
The best studied of these is the rod cell light sensitive photopig-
ment, rhodopsin, which is mutated in approximately 30% of cases
of ADRP, (Wang et al., 2005) making it one of the most common
causes of RP. Rhodopsin is comprised of the rod opsin protein and
the chromophore 11-cis-retinal. Over 140 mutations have been
identiﬁed in rod opsin (RetNet, http://www.sph.uth.tmc.edu/
RetNet/). These mutations have been classiﬁed according to their
cellular or biochemical properties (reviewed by Stojanovic and
Hwa, 2002; Mendes et al., 2005). Of particular interest to this
review are the class II mutants that lead to rod opsin protein
misfolding. Class II is the most common class of rod opsin
mutations and includes P23H, which is also the most common
cause of ADRP in North America. Dryja et al. (1990) ﬁrst identiﬁed
the P23H mutation. The proline at position 23 is highly conserved
among vertebrate and invertebrate opsins and in other G-protein
coupled receptors, for example beta-2-adrenergic receptor
(Applebury and Hargrave, 1986). Similarly, many other residues
affected by class II mutations are conserved and reside in the
intradiscal and transmembrane domains that are critical to the
correct folding of the protein (Mendes et al., 2005).2.2. Class II rod opsin protein misfolding and aggregation
Awealth of data from animal models and cell biological studies
has shown that class II rod opsin mutations shift the folding
equilibrium away from the native state and towards folding
intermediates that have a propensity to misfold and aggregate. In
animal models, wild-type (WT) rhodopsin is almost entirely
restricted to the outer segment, a specialized rod photo-sensing
organelle. In contrast, class II rod opsin mutants show abnormal
accumulation in the photoreceptor outer nuclear layer, outer
plexiform layer and are also detected in inner and outer segments
(Roof et al., 1994; Frederick et al., 2001). In cultured cells, WT
opsin translocated to the plasma membrane, whereas class II
mutants were retained in the ER, and could not be reconstituted
with 11-cis-retinal suggesting protein misfolding (Sung et al.,
1991, 1993; Kaushal and Khorana, 1994). The misfolded class II rod
opsin is retrotranslocated from the ER to the cytosol and degraded
by the ubiquitin–proteasome system or can aggregate into
cytosolic aggregates (Illing et al., 2002; Saliba et al., 2002). These
rod opsin aggregates can coalesce into large inclusions (Fig. 3)
with the properties of an aggresome similar to those described for
several polytopic and monotopic integral membrane proteins
(Johnston et al., 1998).
In addition to gain of function mechanisms, misfolded opsin
can act as a dominant negative to affect the processing and fate of
the wild-type protein. Studies on Drosophila Rh1 (Kurada et al.,
1998) and mammalian rod opsin in cells (Saliba et al., 2002; Rajan
and Kopito, 2005) suggested that misfolded rod opsin had a
dominant effect on the WT protein. When both WT and mutant
rod opsin were present, as in patients heterozygous for ADRP,
P23H was found to affect the processing of WT opsin, causing the
wild-type protein to aggregate and form inclusions (Saliba et al.,
2002). Furthermore, the mutant and WT opsins appeared to form
high molecular weight, detergent insoluble complexes, in which
the two proteins were in close (o70 A˚) proximity (Rajan and
Kopito, 2005).
Rod opsin misfolding and aggregation has many similar
features to the protein misfolding and aggregation observed in
other neurodegenerative diseases such as familial amyotrophic
lateral sclerosis (ALS) (Matsumoto et al., 2006), polyglutamine
disease (Gidalevitz et al., 2006) and prion disease (Collinge and
Clarke, 2007). For example, similar to the inclusions in many
neurodegenerations, P23H-opsin inclusions recruit ubiquitin and
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Table 1
Examples of retinal disease genes that have protein misfolding as part of their pathogenesis
Disease Disease gene Function/putative function Loss or gain of function References
Autosomal dominant retinitis
pigmentosa (ADRP)
Rhodopsin Rod photoreceptor light
receptor
Gain of function and
dominant negative
Illing et al. (2002), Saliba et al.
(2002), Rajan and Kopito
(2005)
Inosine monophosphate
dehydrogenase type I
(IMPDH1) (RP10)
IMPDH1 catalyzes the rate-
limiting step of guanine
nucleotide synthesis
Gain of function Aherne et al. (2004)
Carbonic anhydrase IV (RP17) Catalyzation of the reversible
hydration of carbon dioxide
for buffering extracellular pH
levels
Loss of function or gain of
function
Bonapace et al. (2004),
Rebello et al. (2004), Yang et
al. (2005)
Bardet–Biedl Syndrome (BBS)
and MMKS
MKKS/BBS6 Centrosomal protein, required
for cilia/basal body function
Loss of function Hirayama et al. (2007)
Best vitelliform macular
dystrophy
Bestrophin 1 (best 1) Regulation of voltage gated
Ca(2+) channels
Loss of function Kunzelmann et al. (2007),
Burgess et al. (2008)
Doyne honeycomb macular
dystrophy
EGF-containing ﬁbulin-like
extracellular matrix protein 1
Extracellular matrix protein of
unknown function
Loss of function Marmorstein et al. (2002)
Leber congenital amaurosis
(LCA) and early onset
retinal dystrophy (EORD)
RPE65 Retinoid isomerase Loss of function Hamel et al. (1993), Chen et al.
(2006), Takahashi et al. (2006)
AIPL1 Retina-speciﬁc co-chaperone Loss of function Ramamurthy et al. (2003), van
der Spuy and Cheetham
(2004)
Spinocerebellar ataxia 7 SCA7 Component of TFTC and
STAGA transcription factor
complexes
Gain of function Bowman et al. (2005)
Stargardt disease Elongase of very long chain
fatty acids-4 (ELOVL4)
Elongation of very long chain
fatty acids
Gain of function and
dominant negative
Karan et al. (2004), Grayson
and Molday (2005)
ATP-binding cassette (ABC)
transporter A4 (ABCA4)
Transports all-trans retinal
and/or derivatives across
outer segment discs
dependent manner
Loss of function Wiszniewski et al. (2005)
X-linked progressive retinal
atrophy (XLPRA)
RPGR (retinitis pigmentosa
GTPase regulator)
Function unknown, protein
localizes to centrioles, ciliary
axonemes and microtubular
transport complexes
Loss of function Zhang et al. (2002)
X-linked retinoschisis Retinoschisin (RS1) Cell adhesion protein Loss of function Wang et al. (2002), Wu and
Molday (2003)
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toxicity of class II rhodopsin mutations remains to be elucidated
but it is likely that similar gain of function mechanisms apply as in
other neurodegenerations (see Mendes et al., 2005 for more
detail). Therefore, it is important that we consider the role of
chaperones in opsin biogenesis and their role in opsin quality
control and degradation.2.3. Rod opsin interacts with multiple ER chaperones
during biogenesis
The biogenesis and quality control of multi-spanning mem-
brane proteins occurs at the ER. Certain steps in this pathway and
the potential involvement of molecular chaperones are shown
schematically in Fig. 3. The rod opsin signal sequence binds to the
signal recognition particle (Audigier et al., 1987) directing
the ribosome and the growing polypeptide to the ER membrane.
This signal sequence is not cleaved (Friedlander and Blobel, 1985)
and opsin inserts in the ER co-translationally (Kanner et al., 2002).
The rod opsin transmembrane domains are thought to undergo
active and passive displacement from the Sec61 translocon into
the lipid bilayer (Ismail et al., 2006). PAT-10, a transmembrane
speciﬁc chaperone, associates with the TM1 of rod opsin until the
entire polypeptide chain has been translocated, either facilitating
insertion or modulating the assembly of individual transmem-
brane domains (Meacock et al., 2002).Upon insertion into the ER membrane the N-terminal intra-
discal domain of rod opsin is N-glycosylated at Asn2 and Asn15 by
the oligosaccharyl transferase enzyme (Plantner et al., 1980; Kean,
1999). Glycans are known to be required for the association with
lectin chaperones that can either assist in polypeptide folding or
ER-associated degradation (ERAD) of a terminally misfolded
protein. Glycan chains are required for efﬁcient ERAD of misfolded
rod opsin (Saliba et al., 2002). These data imply a role for lectin
chaperones such as calnexin, calreticulin or EDEM in opsin quality
control, but the speciﬁc lectin chaperones that regulate opsin
ERAD remain to be identiﬁed. Other chaperones may also regulate
opsin quality control. For example, Anukanth and Khorana (1994)
showed that mutant opsins were found in a complex with the
Hsp70 and Hsp90 chaperones of the ER, namely Grp78 (BiP), and
Grp94.
An increase in BiP mRNA levels was induced in cells by P23H
rod opsin expression compared to WT rod opsin or GFP
expression, suggesting that the protein misfolding associated
with class II rod opsin can induce the unfolded protein response
(UPR) (Lin et al., 2007). However, in transgenic P23H rats, BiP
mRNA levels decreased as the retina degenerated, whereas CHOP
mRNA was induced (Lin et al., 2007). These data suggest that
photoreceptors may be unable to adapt to the production of P23H
rod opsin by upregulating their ER resident chaperones via the
UPR. Sustained signaling through the PERK branch of the UPR is
associated with the induction of the proapoptotic factor CHOP
which may lead to cell death. Therefore, a failure of the chaperone
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Fig. 3. The role of chaperones in rod opsin biogenesis, quality control and degradation. Schematic representation of rod opsin folding and misfolding. Rod opsin does not
encode a cleaved amino-terminal signal sequence, but is still thought to enter the secretory pathway by co-translational or post-translational insertion into the ER via the
ER translocon. The ER translocon is thought to align with the large ribosomal subunit to facilitate entry and prevent ﬂow of ions from the ER. The ER Hsp70, BiP, located in
the luminal side, assists with protein insertion by a ‘ratchet mechanism’ coupled to ATP hydrolysis. The Hsp40 protein Sec63 interacts with BiP through its J-domain and
modulates BiP function (Misselwitz et al., 1998). Properly folded rod opsin, with the correct disulphide linkage (Hwa et al., 1999) will translocate to the Golgi for further
processing. In contrast, mutant opsin is more likely to misfold and form the wrong disulphide bond (Hwa et al., 1999) and will be retained in the ER by resident chaperones
such as Grp94 or BiP (Anukanth and Khorana, 1994). The misfolded rod opsin may also interact with HSJ1b in the cytoplasm and a lectin chaperone in the ER lumen. Mutant
opsin is degraded by the proteasome in the cytoplasm following ERAD. If the ERAD machinery is overwhelmed, mutant opsin aggregates upon dislocation in the cytosol
(Illing et al., 2002; Saliba et al., 2002). These aggregates in turn set up a positive feedback loop by inhibiting the proteasome and enhancing aggregation (Illing et al., 2002).
The aggregated opsin can coalesce into large aggregates, eventually forming visible inclusions. These inclusions and aggregates sequester cellular proteins, including
molecular chaperones such as Hsp70 and HSJ1.
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photoreceptor cell death.
Speciﬁc lectins for the maturation and processing of mamma-
lian rod opsin have not yet been identiﬁed. Calnexin is required,
however, for the maturation of the Drosophila rod opsin protein,
Rh1, a homologue of mammalian rod opsin (Rosenbaum et al.,
2006). Flies with premature stop codons in their cnx gene
displayed reduced levels of cnx transcript with no detectable
calnexin protein. These mutations severely reduced Rh1 protein
levels, suggesting that Rh1 degradation was taking place.
Furthermore, cnx mutant ﬂies displayed age-related retinal
degeneration as shown by reduced translocation of Rh1 to
rhabdomeres 1–6 and reduced rhabdomere size. Calnexin also
formed a stable complex with Rh1, consistent with its role as
molecular chaperone (Rosenbaum et al., 2006). There may be,
however, signiﬁcant differences between Rh1 and mammalian rod
opsin in this respect. An intact carbohydrate unit does not appear
to be essential for the chromophoric properties of rhodopsin or forits regeneration (Renthal et al., 1973). Furthermore, Kaushal et al.
(1994) showed that treatment of WT opsin with the glycosylation
inhibitor, tunicamycin, resulted in non-glycosylated opsin, which
translocated to the cell surface and formed the characteristic
rhodopsin chromophore with 11-cis-retinal. On the other hand,
treatment of P23H opsin expressing cells with tunicamycin led to
P23H accumulation in the ER, suggesting that glycans are required
for mutant rod opsin ERAD (Saliba et al., 2002). Other proteins
that undergo ERAD have been shown to dislocate to the cytosol
where they are deglycosylated by cytosolic N-glycanases, suggest-
ing that the carbohydrates are recognized by lectins that mediate
and process the misfolded polypeptides for degradation by the
proteasome (Wiertz et al., 1996a, b; Peta¨ja¨-Repo et al., 2001; Gong
et al., 2005). The actual targeting into ERAD of misfolded opsin
could be mediated by chaperones that may not interact with
normal folding intermediates. This is the case for the cystic
ﬁbrosis transmembrane conductance regulator (CFTR) where
Hsp90 is required for the folding of its large cytoplasmic domains
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(Loo et al., 1998; Youker et al., 2004; Zhang et al., 2006).
Other evidence suggests that Rh1 and mammalian opsin may
have different chaperone requirements. NinaA is an ER resident
integral membrane peptidyl–prolyl isomerase (PPI) chaperone
that is required for the maturation of Rh1 rhodopsin. NinaA
mutant ﬂies have very little Rh1 opsin in their rhabdomeres, with
most of Rh1 immunoreactivity associated with ER membranes
(Colley et al., 1991; Stamnes et al., 1991; Baker and Zuker, 1994).
These ﬁndings suggest that NinaA activity is required for the
transport of Rh1 from the ER. Furthermore, examination of NinaA
mutants revealed reduced levels of rhodopsin and large accumu-
lations of rough ER membranes (Colley et al., 1991). In contrast,
heterologous expression of bovine rod opsin in Drosophila resulted
in correctly folded and processed rod opsin even in the absence of
NinaA (Ahmad et al., 2006). The reasons for this difference in
chaperone requirement remains to be elucidated but may help in
clarifying the role of chaperones in mammalian opsin biogenesis.
2.4. Non-ER chaperone opsin interactions
The retina is rich in chaperones and several could be involved
in rod opsin biogenesis or the response to rod opsin misfolding.
For example, almost 20 different crystallin genes have been
identiﬁed in the retina (Xi et al., 2003). The crystallins can be
divided into two major families, a and bg with a-crystallins being
members of the sHsp family of molecular chaperones. In the
retina, a-crystallin co-puriﬁed with post-Golgi membranes from
frog photoreceptors and, therefore, could be involved in the
transportation of newly synthesized rhodopsin, suggesting that
these chaperones might participate in the renewal of the
photoreceptor outer segment (Deretic et al., 1994).
In addition, specialized Hsp40 (DnaJ) proteins are expressed at
relatively high levels in the retina compared to other tissues.
HSJ1a and HSJ1b are neuronal Hsp40 proteins that are present in
all layers of the neural retina and have distinct staining patterns,
with HSJ1b found to be enriched at the site of rhodopsin
production (Chapple and Cheetham, 2003). Heterologous expres-
sion in cell culture showed that the HSJ1b isoform increased the
incidence of WT and P23H rod opsin inclusions, and increased the
retention of the WT protein in the ER. This was not observed with
HSJ1a or the C321S HSJ1b prenylation null mutant (Chapple and
Cheetham, 2003). These Hsp40 proteins act as neuronal shuttling
factors for the sorting of chaperone clients to the proteasome
(Westhoff et al., 2005). HSJ1 proteins colocalized with rod opsin in
inclusions, suggesting that they may be part of the opsin
degradation pathway. The full signiﬁcance of the interaction of
HSJ1 proteins with rod opsin remains to be determined; however,
it is clear that the retina has specialized chaperones that are
essential for normal vision.
2.5. Chaperone inducers and retinal protein misfolding disease
It is now widely accepted that chaperones can act as protectors
of the proteome and may be manipulated to combat protein
misfolding diseases. The over-expression of molecular chaperones
can extend life span in the nematode and fruit ﬂy (Tatar et al.,
1997; Hsu et al., 2003). Molecular chaperones have been shown to
suppress aggregate formation of mutant proteins that cause
neurodegenerative diseases, such as spinocerebellar ataxia 1
(SCA1) (Cummings et al., 1998), spinal and bulbar muscular
atrophy (SBMA) (Kobayashi et al., 2000), familial amyotrophic
lateral sclerosis (FALS) (Takeuchi et al., 2002) and Huntington
disease (Jana et al., 2000; Westhoff et al., 2005). Therefore, it may
be possible to alleviate protein misfolding diseases by enhancingthe expression of molecular chaperones using drugs. A chaperone
inducer is a drug that can activate heat shock transcription factors
(HSFs) and induce chaperone expression. Several drugs that can
induce chaperones are now in clinical trials. For example, drugs
based around the Hsp90 inhibitor geldanamycin, such as 17-
allylamino-17-demethoxygeldanamycin (17-AAG), induce HSF
activity. In a cell culture model of rhodopsin RP based on P23H
rod opsin, treatment with 17-AAG led to a dose-dependent
reduction of inclusion incidence. This correlated with an increase
in cell viability and a reduction in caspase activation (H.F. Mendes
and M.E. Cheetham, under review). Therefore, manipulation of
chaperones either by drugs or by gene manipulation may be
useful to treat photoreceptor protein misfolding diseases.3. Putative chaperones as retinal disease genes
In the last 10 years the expanding list (http://www.sph.uth.tmc.
edu/Retnet/home.htm) of retinal disease genes has identiﬁed
several putative chaperone proteins as being essential either in
the development or maintenance of a functional retina. These
chaperones and putative chaperones are shown in Table 2. In
contrast to ADRP, all of these diseases are caused by loss of protein
function, highlighting that a lack of chaperone function can be
critical to many aspects of photoreceptor cell biology.
3.1. RP2
X-linked RP (XLRP) is generally associated with the most severe
forms of RP. Mutations in the RP2 gene account for approximately
15% of all XLRP cases (Schwahn et al., 1998; Hardcastle et al., 1999;
Miano et al., 2001). The RP2 protein is widely expressed in human
tissues and does not appear to be enriched in retina (Chapple
et al., 2000). As patients with RP2 mutations appear to have only
retinal pathology without any other organ involvement, it is not
clear why the loss of RP2 leads speciﬁcally to RP. RP2 is a putative
chaperone based on its homology to a previously identiﬁed
chaperone in the tubulin folding pathway. RP2 is a 350 amino acid
protein, which contains a homology domain of 151 amino acids
(30% identity) to the tubulin cofactor C (TBCC). Most of the
reported RP2 missense mutations correspond to this region and
lie within the residues conserved with TBCC.
TBCC, together with other speciﬁc cofactor chaperones (tubulin
cofactors A–E, TBCA, TBCB, TBCD and TBCE), acts downstream of
the cytosolic chaperonin CCT in the tubulin folding pathway (Tian
et al., 1996). Tubulin heterodimers cannot form without the
assistance of molecular chaperones (Lewis et al., 1992; Yaffe et al.,
1992). Once quasi-native a and b tubulin have been released from
CCT, these cofactors facilitate the assembly of the a/b tubulin
heterodimer and stimulate the GTPase activity of the b tubulin
within the heterodimer, leading to the formation of native tubulin
heterodimers (Tian et al., 1999). This process is regulated by ADP
ribosylation factor-like 2 (Arl2) (Bhamidipati et al., 2000; Shern
et al., 2003). Correct expression of the tubulin cofactors TBCC,
TBCD and TBCE is vital, as mutations in these genes lead to a lack
of microtubules and failure of cell division in Aradopsis (Steinborn
et al., 2002, Kirik et al., 2002). In addition, TBCD also functions as a
centrosomal protein. Over expression of TBCD in HeLa cells lead to
the loss of gamma tubulin at the centrosomes and cells appeared
compromised in their ability to nucleate microtubules. Whereas
loss of TBCD caused failure of cytokinesis and an increase in cells
with mitotic spindle defects (Cunningham and Kahn, 2008).
The similarity between RP2 and TBCC suggested a potential
overlap in function. This hypothesis was supported by in vitro
studies that demonstrated RP2, in conjunction with TBCD, could
partly substitute for TBCC function as a tubulin-GTPase activating
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Table 2
Retinal dystrophies associated with mutations in chaperones or co-chaperones
Disease Disease gene Phenotype Chaperone system Function/putative
function
References
Bardet–Biedl Syndrome
(BBS)
McKusick–Kaufman
Syndrome (MKKS)/BBS6
Retinal degeneration Type II chaperonin
homology
Centrosomal protein,
possibly involved in
cilia/basal body function
Stone et al. (2000),
Katsanis et al. (2000),
Kim et al. (2005), Ross et
al. (2005), Hirayama et
al. (2007)
Obesity
Post-axial polydactyly
BBS10 Retinal degeneration Type II chaperonin
homology
Centrosomal protein,
possibly involved in
cilia/basal body function
or protein–protein
interactions
Stoetzel et al. (2006)
Obesity
Cognitive impairment
Genito-urinary tract
malformations
BBS12 Retinal degeneration Type II chaperonin
homology
Centrosomal protein,
possibly involved in
cilia/basal body function
or protein–protein
interactions
Stoetzel et al. (2007)
Obesity
Cognitive impairment
Genito-urinary tract
malformations
Leber congenital
amaurosis (LCA)
Aryl hydrocarbon
receptor interacting
protein-like 1 (AIPL1)
Blindness at birth TPR protein, Hsp70/
Hsp90 co-chaperone
Modulation of NUB1
nuclear translocation;
interaction with and
facilitation of protein
farnesylation; post-
translational synthesis,
biogenesis or assembly
of phosphodiesterase
(PDE) subunits
Sohoki et al. (2000),
Ramamurthy et al.
(2003, 2004), van der
Spuy and Cheetham
(2004, 2006), Liu et al.
(2004), Hidalgo de
Quintana et al. (2008)
No detectable ERG
Retinal dysfunction and
degeneration
NFM5a (rd13) mutant
mouse
Prefoldin (PFDN) 5 Photoreceptor
degeneration, abnormal
outer segment
development
PFD chaperone system Actin and tubulin
folding
Lee et al. (2006)
X-linked retinitis
pigmentosa (XLRP)
RP2 Retinal degeneration Homology to tubulin
speciﬁc chaperone C
(TBCC)
Plasma membrane
localization,
involvement in tubulin
biogenesis
Schwahn et al. (1998),
Chapple et al. (2000),
Grayson et al. (2002)
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mutation in the conserved arginine residue, R118H in RP2,
abolished the tubulin GAP activity in both RP2 and cofactor C,
suggesting that this residue could be an ‘arginine ﬁnger’, which
triggers the tubulin GAP activity. However, RP2 was not able to
replace TBCC in the tubulin heterodimerization reaction (Bartolini
et al., 2002). Similarly, RP2 cannot be functionally substituted by
TBCC, as TBCC does not compensate for RP2 in rods of XLRP
patients (Grayson et al., 2002).
There are several clear differences between RP2 and TBCC. For
example, RP2 is subject to posttranscriptional modiﬁcation by
myristoylation and palmitoylation at its N-terminus, which target
RP2 to the plasma membrane (Chapple et al., 2000, 2002, 2003;
Grayson et al., 2002). RP2 acylation is disrupted by a patient
mutation deletion of serine 6 (DS6), which prevents the correct
sub-cellular targeting of RP2. Therefore, aberrant post-transla-
tional modiﬁcation and localization of RP2 might cause RP in
these patients (Chapple et al., 2000). Furthermore, the C-termini
of RP2 and TBCC are not similar. The C-terminus of RP2 shows
structural similarity with nucleoside diphosphate kinase 1 (NDK1)
(Evans et al., 2006; Kuhnel et al., 2006). NDKs catalyze the transfer
of phosphates, mainly from ATP to cognate NDPs generating
nucleoside triphosphates (NTPs), and can also have autopho-
sphorylation activity from ATP and GTP (reviewed by Hasunama
et al., 2003). Previously, NDK was shown to interact with Hsp70
(Leung and Hightower, 1997), while Hsp70, similar to NDK,
exhibits an intrinsic ADP–ATP phosphorylation activity (Hiromura
et al., 1998). Therefore, functionality of the RP2 C-terminal NDK
domain could provide further evidence for molecular chaperone
activity. RP2 does not have nucleoside diphosphate kinase activity,
but it does share exonuclease activity with NDK 1 and 2 (Yoonet al., 2006). Furthermore, RP2 translocated to the nucleus upon
induced DNA damage, potentially linking RP2 with the cellular
stress response machinery (Yoon et al., 2006).
The only identiﬁed interaction partner of RP2 is the ADP
ribosylation factor (Arf)-like protein Arl3 (Bartolini et al., 2002).
The afﬁnity of RP2 to GDP bound Arl3 is 400-fold weaker than to
GTP-bound Arl3, indicating that RP2 is a bona ﬁde effector of Arl3
(Kuhnel et al., 2006). Myristoylation of RP2 also decreases this
afﬁnity, leading to the proposal that Arl3 might interact with
unmodiﬁed RP2 and facilitate RP2 targeting for acylation (Chapple
et al., 2000; Bartolini et al., 2002; Kuhnel et al., 2006). Arl3 is a
ubiquitous microtubule associated protein (MAP) and localized to
the connecting cilium in photoreceptors (Grayson et al., 2002).
The connecting cilium functions as a specialized sensory axoneme
that extends from the cell body of the photoreceptor to form the
outer segment. The link between retinal degeneration and
dysfunction of this cilium has become increasingly evident, as
many RP causing proteins, such as the retinitis pigmentosa GTPase
regulator (RPGR), have been localized to cilia and shown to be
essential for cilia function. RPGR is another major cause of XLRP
(Meindl et al., 1996, reviewed by Adams et al., 2007) and RPGR is
anchored to the connecting cilium by another retinal disease gene
product the RPGR-interacting protein (RPGRIP), a structural
component of the ciliary axoneme (Hong et al., 2001). Interest-
ingly, Arl3 interacts with the phosphodiesterase delta (PDEd),
which is also an interacting partner of RPGR (Linari et al.,
1999a, b). The signiﬁcance of these protein interactions remains
to be clariﬁed.
Arl3 may have other cytoskeletal functions, especially as the
protein is present at microtubule-rich structures, such as centro-
somes, mitotic spindle and midbodies, in a wide variety of cell
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acetylation of alpha-tubulin, leading to failure of cytokinesis and
an increased number of binucleated cells (Zhou et al., 2006).
As yet, Arl3 has not been shown to cause retinal dystrophy in
humans, but studies in mice deﬁcient in Arl3, revealed that this
protein is essential for photoreceptor and kidney development
(Schrick et al., 2006). Arl3 knock-out mice showed abnormal
epithelial cell proliferation and cyst formation in kidney, liver and
pancreas, in the retina there was photoreceptor degeneration
(Schrick et al., 2006). Overall, this phenotype is consistent with a
failure of function or signal transduction in primary cilia. The
formation of cilia is coordinated with progression through the cell
cycle via speciﬁc signaling pathways and there is growing
evidence that defects in these pathways cause proliferative
diseases, such as cystic disorders in kidney, liver and pancreas
(reviewed by Quarmby and Parker, 2005). The link between Arl3
and cilia function, however, strengthen the notion that RP2 may
be required for specialized elements of the cytoskeleton in
photoreceptors.
Further evidence for a relationship of RP2 and cilia function
was obtained when a homologue of TBCC and RP2 was identiﬁed
in trypanosomes (TbRP2). Ablation of TbRP2 caused shortened
ﬂagella and defective axonemal microtubule formation, but had
no effect on other microtubule structures or functions including
spindle formation. TbRP2 localized to the mature basal body of
the ﬂagellum, suggesting ﬂagellum speciﬁc functions of the
protein. One of these functions appears to be the recruitment
and possibly monitoring the quality of carboxyl-tyrosinated alpha
tubulin prior to cilia assembly (Stephan et al., 2007). These
ﬁndings suggest that RP2 may cause XLRP through problems in
assembly and chaperoning of components of the primary cilia.
However, there are striking structural differences between the
RP2 protein in humans and trypanosomes. For example, TbRP2
lacks the C-terminal NDK domain, as well as the N-terminal dual
acylation motif, both of which are likely to contribute to RP2
function as patient mutations compromise these motifs. These
differences might be crucial to explain why the RP2 phenotype is
restricted to the retina, despite the ubiquitous expression of the
protein and importance of cilia in other organs. The importance of
specialized chaperones in cilia function, however, is now becom-
ing clear through the identiﬁcation of causative genes in cilia
diseases or ‘ciliopathies’.3.2. Bardet– Biedl Syndrome (BBS) proteins
Bardet–Biedl Syndrome is a pleiotropic, genetically hetero-
geneous disorder caused by defects in primary cilia and/or basal
body proteins in several organs. The BBS genes identiﬁed to date
show limited structural and functional similarities despite the fact
that mutations in BBS genes give rise to the same undistinguish-
able phenotype. Generally patients suffer from retinal dystrophy,
renal dysplasia, postaxial polydactyly, obesity and hypogonadism
with infertility in males [OMIM 209900].
Since the ﬁrst BBS gene (BBS6) was identiﬁed in 2000
(Slavotinek et al., 2000; Katsanis et al., 2000), 12 genes (BBS1-
12) have been identiﬁed. BBS1 and BBS10 are the most common
BBS loci, accounting for 23–56 and 20% of mutations, respectively
(reviewed by Blacque and Leroux, 2006). To date no correlation
between genotype and phenotype has been established.
BBS1, BBS2 and BBS7 proteins have predicted beta-propeller
domains, which are common motifs implicated in a variety of
functions, such as enzyme catalysis, scaffolding and signaling,
ligand binding and transport, as well as mediation of protein–
protein interactions (Jawad and Paoli, 2002). Interestingly, many
beta propeller domain proteins (such as Gb) are clients forchaperonin based protein folding, presumably because of parti-
cular structural requirements of this type of fold (Kubota et al.,
2006). Several good animal models of BBS have been produced.
For example, the BBS1 (M390R) knock-in mouse model presented
with retinal degeneration, decreased olfaction, obesity and lack of
sperm ﬂagella, resembling phenotypes of other BBS mouse
models. The BBS1 mutant knock-in mice showed severe photo-
receptor degeneration with disrupted morphology and orientation
of outer segment membranes (Davis et al., 2007). In addition,
many BBS patients suffer from hypoosmia or anosmia, indicating
lack or dysfunction of olfactory sensory cilia. This hypothesis has
been conﬁrmed using mice which lack BBS1 or BBS4. These mice
showed a reduction in the olfactory ciliated border, as well as
defects in dendritic microtubule organization and trapping of
olfactory cilia proteins in dendrites and cell bodies (Kulaga et al.,
2004, reviewed by Fliegauf et al., 2007).
Interestingly, the BBS3 gene encodes the Arl6 protein, which
like Arl2 and Arl3 is a member of the Arf subfamily of Ras related
proteins (Fan et al., 2004). Unfortunately, not much is known
about the function of Arl6, but a worm orthologue of the protein is
expressed in sensory neurons and is proposed to trafﬁc along cilia
by intraﬂagellar transport (IFT), supporting a role for Arl6 in cilia
function (reviewed by Kahn et al., 2005).
In a recent study, seven BBS proteins (BBS1, BBS2, BBS4, BBS5,
BBS7, BBS8 and BBS9) were shown to form a biochemically stable
protein complex, the ‘BBSome’ (Nachury et al., 2007). This
complex transiently associated with pericentriolar material 1
(PCM-1) and alpha tubulin, as well as localizing to the membrane
of the primary cilium. Knock-down of BBS1 and BBS5 affected
ciliogenesis by interfering with membrane trafﬁcking to the
cilium. In addition, Rabin8 a guanosyl exchange factor for Rab8,
which facilitates vesicular trafﬁcking between different compart-
ments, was associated with the BBSome. Therefore, BBS proteins
may function in membrane trafﬁcking in the primary cilium
(Nachury et al., 2007). These data led to the proposal that the
genetic complexity of BBS can be reduced to two highly conserved
entities, the core BBSome and the small GTPase Arl6/BBS3, while
all other BBS genes are limited to chordates and are possibly
regulators of the BBSome or Arl6/BBS3 (Nachury et al., 2007).
Curiously, the BBS genes excluded from the BBSome, BBS6, BBS10
and BBS12 are all limited to the vertebrate lineage (or possibly
chordates for BBS6) and deﬁne a divergent branch of chaperonin-
like proteins (Kim et al., 2005; Stoetzel et al., 2006, 2007).
Sequence analysis of BBS12 showed that BBS12, together with
BBS6 and BBS10 are similar to type II chaperonins. All three
proteins have a typical chaperonin-like organization, encompass-
ing the three major functional domains: equatorial, intermediate
and apical. However, compared to prototypic type II chaperonins
BBS6, BBS10 and BBS12 contain speciﬁc insertions in the
equatorial and the apical domains. Here BBS12 shares with BBS6
the same insertions in the core chaperonin fold of the equatorial
domain and with BBS10 in the apical domain. Given the structural
constraints introduced by the additional domains it was predicted
that it is unlikely that BBS6, BBS10 and BBS12 are involved in the
assembly of a prototypic chaperone complex similar to CCT
(Stoetzel et al., 2006, 2007). However, the presence of additional
domains within the proteins might confer a speciﬁc binding or
protein folding capacity to these BBS proteins, which is lacking in
other type II chaperonins.
This might be especially important as BBS6 and BBS12 lack
several residues critical for ATP binding and hydrolysis, which are
important in other chaperonins for protein folding (Kim et al.,
2005; Stoetzel et al., 2007). In contrast to BBS6 and BBS12, the
functional motif for ATP hydrolysis is conserved in BBS10,
suggesting that BBS10 might function as an active enzyme
(Stoetzel et al., 2006). These ﬁndings highlight an important role
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since these three BBS genes account for approximately 30% of BBS
mutations (Stoetzel et al., 2007).
Suppression of either BBS6, BBS10 or BBS12 in zebraﬁsh
yielded gastrulation-movement defects characteristic of other
BBS morphants, whereas simultaneous suppression of all three
chaperonin-like BBS proteins resulted in severely affected em-
bryos, possibly hinting at a partial functional redundancy within
this protein family (Stoetzel et al., 2007).
BBS6 and BBS10 (and possibly BBS12) are centrosomal proteins
(Stoetzel et al., 2007) and BBS6 expression is required for
cytokinesis (Kim et al., 2005). In addition, knock-down of BBS6
has been implicated in planar cell polarity (PCP) defects (Ross
et al., 2005). The fact that BBS6, BBS10 and BBS12 arose only in the
vertebrate lineage, whilst architecture and function of the basal
body and cilium have been conserved rigorously during evolution
might indicate the acquisition of novel cilia functions and/or
requirements coincident with the emergence of these particular
type II chaperonins. The three BBS proteins might have co-evolved
with vertebrate speciﬁc proteins, which are involved in basal body
and/or cilia assembly and function. Structural analysis of BBS6
revealed that the protein might function as a subunit of a novel
hetero-oligomeric type II chaperonin (Chapple et al., 2001). Due to
the similarity between BBS6, BBS10 and BBS12, it seems feasible
to speculate that these three BBS proteins could form a larger,
multi-subunit complex, possibly in conjunction with other, yet
unknown proteins. Therefore, studies addressing whether BBS6
alone or together with BBS10 and BBS12 forms a novel chaperonin
complex could provide further insights into disease pathogenesis
and lead to the identiﬁcation of new chaperonin client proteins,
which might represent causative BBS genes.3.3. Prefoldin 5
Prefoldin (PFDN, also termed GimC complex, genes involved in
microtubule biogenesis complex) is a heterohexameric chaperone
that cooperates in the folding of nascent protein chains with
cytosolic chaperonin CCT. The interaction of PFDN with non-
native protein chains protects them from aggregation and
degradation until their transfer to CCT, where the ﬁnal protein
folding steps occur (Vainberg et al., 1998). Therefore, PFDN can be
considered to function as a co-chaperonin, even though its role
seems to be different from so-called classical co-chaperonins,
such as GroES, which acts as a cap for the GroEL cylinder. PFDN is
a 90 kDa complex, comprising two alpha and four beta subunits,
which form a jellyﬁsh-like structure (Fig. 1). PFDN binds the
exposed hydrophobic residues of unfolded proteins via a so-called
hydrophobic groove at the distal end of one of the mobile beta
subunits. Following b subunit–client interaction the a subunits
change their conformations and positions. This leads to an
adjustment of the width of the central PFDN cavity depending
on the mass of the bound substrate (Ohtaki et al., 2007).
The major targets for PFDN binding are considered to be actin,
as well as a and b tubulin. The binding of unfolded actin and PFDN
results in a conformational change of the actin protein giving rise
to a rod-like shaped protein, which is then recognized by CCT. It
seems likely that the unfolded actin chain requires folding into a
quasi-native conformation before an interaction with CCT can
occur. In addition, PFDN does not release the pre-folded protein
into the cytosol, but physically interacts with CCT, forming a
PFDN:client:CCT complex (Martin-Benito et al., 2002; Zako et al.,
2005).
Interestingly, introduction of a point mutation in the prefoldin
5 (PFDN5) gene was reported to cause abnormal photoreceptor
outer segment development in a recessive mouse model of retinaldystrophy (NMF5a corresponding to rd13) (Lee et al., 2006;
Abstract presented at the Association for Research and Vision
2006, Poster no. 2296). This mutation, which was introduced by
ENU mutagenesis, leads to the amino acid substitution L110R in
PFDN5. In the mutant mice outer and inner segment cell thickness
was reduced compared to WT littermate controls. In addition,
rhodopsin and rom1, a protein important for regulation of
morphogenesis and stabilization of the outer segment, were
mislocalized in the mutant mice. These ﬁndings suggest that
transport via the connecting cilium to the outer segment might be
impaired or poorly developed in the PFD mutant mice. The
cytoskeleton of the connecting cilium consists mainly of micro-
tubules and actin ﬁbres, which are crucial for transport of
molecules from the outer segment and morphogenesis of the
outer segment disk membranes, respectively. Since microtubules
and actin are the main client proteins of PFDN binding it seems
likely that mutations in PFDN5 impair the correct folding of vital
components of the connecting cilium, compromising its integrity.
However, this hypothesis does not explain why the observed
phenotype of the PFDN5 mutation is mainly retinal. Further
characterization of this mouse model may reveal novel chaperone
roles for PFDN in the retina, possibly by interacting with retina
speciﬁc proteins or other molecules relevant for retinal function.3.4. AIPL1
Leber congenital amaurosis (LCA) is a genetically heteroge-
neous, inherited retinopathy characterized by rapid degeneration
of rod and cone photoreceptors shortly after birth (Sohocki et al.,
2000). Blindness normally occurs within the ﬁrst year of life,
making this the most severe form of inherited retinal dystrophy.
LCA has been shown to be caused by mutations in the
photoreceptor and pineal-speciﬁc aryl hydrocarbon receptor
interacting protein-like 1 (AIPL1) (Sohocki et al., 2000), and
investigations are currently aimed at dissecting the normal
functions of this protein.
AIPL1 is expressed in both rod and cone photoreceptors of the
developing retina (van der Spuy et al., 2003) but is restricted to
rods in the adult retina (van der Spuy et al., 2002). The reason for
this developmental switch is unclear but indicates an important
role of AIPL1 in mature rod cell function, in addition to a role in
functional development of the human retina. AIPL1 was named
due to its homology (49% identity) with the Aryl hydrocarbon
receptor (AhR)-interacting protein (AIP), also known as the human
X-associated protein 2 (XAP2) or AhR-activated 9 (AhR9)
(Kuzhandaivelu et al., 1996; Carver and Bradﬁeld, 1997; Ma and
Whitlock, 1997). AIP is a co-chaperone similar to the immuno-
philins (FKBP51/52), which interact with the Hsp90 chaperone
machinery through their tetratricopeptide (TPR) motif to promote
the functional maturation of their respective client proteins, the
AhR and the steroid hormone receptors. AIPL1 has 3 TPR motifs
(van der Spuy, 2006). The conservation of the TPR domain in AIPL1
suggests that it may function as a retina-speciﬁc co-chaperone
involved in the regulation of cognate clients in an analogous
manner to AIP. Indeed, it has recently been shown that AIPL1
interacts with both Hsp90 and Hsp70, and that disease-causing
mutations within the TPR domains diminish these associations
(Hidalgo de Quintana et al., 2008).
Several potential AIPL1 client proteins have been identiﬁed,
through a combination of yeast two hybrid screens and analyses
of animal models. One potential client is the widely expressed
NEDD8 ultimate buster 1 (NUB1), which has been identiﬁed as an
AIPL1-interacting protein (Akey et al., 2002). NUB1 is predomi-
nantly a nuclear protein involved in orchestrating the proteasomal
degradation of the ubiquitin-like proteins NEDD8 and FAT10 and
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Fig. 4. Potential roles of AIPL1 in photoreceptors. Schematic representation showing potential roles of AIPL1 within photoreceptors. AIPL1 is able to modulate the nuclear
localization of NUB1, which may affect the NUB1 NEDD8 and FAT10 ‘busting’ activity (1); AIPL1 interacts with and enhances stability of the PDE holoenzyme (2); AIPL1 may
enhance transport and stability of farnesylated proteins to the ER (3) or other target membranes (4). AIPL1 is likely to utilize the Hsp70 and Hsp90 chaperone machinery to
execute its cellular functions.
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Hipp et al., 2004). It appears to function as an adaptor protein for
the proteasome through associations mediated by its ubiquitin-
like (UBL) and ubiquitin-associated (UBA) domains. Interestingly,
AIPL1 was shown to modulate the nuclear translocation of NUB1
in a manner analogous to the action of AIP on the AhR (van der
Spuy and Cheetham, 2004) (Fig. 4). In addition, AIPL1 acted like a
chaperone to suppress the aggregation of NUB1 fragments into
inclusion bodies. This effect was speciﬁc for NUB1, as it had no
effect on inclusion formation of other aggregation-prone proteins,
such as P23H rod opsin or a mutant polyglutamine expanded
huntingtin fragment (van der Spuy and Cheetham, 2004). More
recently, AIPL1 was shown to cooperate with Hsp70 in reducing
the formation of NUB1 fragment inclusions (Hidalgo de Quintana
et al., 2008). It will also be of interest to determine whether AIPL1
can affect the NUB1-mediated proteasomal degradation of free
and conjugated NEDD8 and FAT10 (Fig. 4). Both of these small
ubiquitin-like proteins have been implicated in cell cycle regula-
tion, suggesting that AIPL1 may regulate photoreceptor growth
and development through modulating NUB1 activity, althoughanimal models of AIPL1 LCA suggest that AIPL1 is not required for
photoreceptor development and differentiation per se (Dyer et al.,
2004; Ramamurthy et al., 2004; Liu et al., 2004).
AIPL1 has also been shown to interact with and enhance
processing of the farnesylated proteins g-transducin and the
Hsp40 protein HDJ2 (Ramamurthy et al., 2003). Retinal lysates
from AIPL1 knockout and hypomorphic mice, however, did not
show global defects in farnesylation, but a speciﬁc reduction in
rod cGMP phosphodiesterase (PDE), a farnesylated heterotrimeric
protein complex that plays an essential role in visual photo-
transduction (Ramamurthy et al., 2004; Liu et al., 2004).
Importantly, all three subunits of the PDE holoenzyme (PDEa, b
and g) were down-regulated at the protein but not mRNA level
prior to disease progression, suggesting AIPL1 may play a role in
the synthesis, assembly and/or stabilization of the PDE protein
complex. In this case, PDE may represent a retina-speciﬁc client of
AIPL1, whereby AIPL1 interacts speciﬁcally with PDEa and
enhances its farnesylation, protecting it from proteasomal
degradation. Given that AIPL1 also interacts with Hsp90 and
Hsp70 (Hidalgo de Quintana et al., 2008), the resulting chaperone
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assembly or quality control of the subunits (Fig. 4). In any case,
the list of retina-speciﬁc client proteins that mediate AIPL1
chaperone function remains to be completed, and future studies
are likely to reveal interesting new insights into the retina-speciﬁc
chaperone activities of AIPL1.4. Conclusions
The retina offers a unique opportunity to study molecular
chaperone function in a highly specialized and accessible part of
the CNS. Several retinal dystrophy genes have mutations that
make the proteins misfold and aggregation prone. The availability
of good in vitro and in vivo models will allow the dissection of the
mechanisms of cell death associated with these misfolding events
and testing of therapies based on manipulating molecular
chaperones. The importance of chaperones to retinal function is
reiterated by the multiplicity of diseases caused by loss of speciﬁc
chaperones. Studying these chaperones in more detail may
enhance our understanding, not only of photoreceptor function,
but also the biology of chaperone networks.Acknowledgements
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Note added in proof
Veltel et al. (2008) recently showed that RP2 could act as a GAP
for Arl3, suggesting that it is a negative regulator as opposed to an
effector.
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